Geoffrey White

Member of SAB. Dr. White is the Co-founder of CBT4CBT, LLC, a computer-based therapy for cognitive behavioral therapy and obtained exclusive rights from Yale through a tough negotiation resulting in a free and clear license with no royal payments. He recently led the successful effort to obtain the first CPT reimbursement code for a stand-alone therapeutic software product. Prior to that, he was the CEO of Canget Bio TekPharma, which is now on the cusp of Phase I clinical trials of its lead anti-cancer molecule. Dr. White has expertise in drug discovery and development; medical device discovery and development; medical software development; FDA interactions and reimbursement strategies; and business strategy. He holds and has held a business and scientific advisory role at numerous companies. He has served over 350 clients as an independent consultant and has helped raise over $170 million in NIH/NSF/DoD funds in the past 10 years.